Marker Therapeutics, Inc.

Analyst Coverage

Marker Therapeutics, Inc. is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Marker Therapeutics, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Marker Therapeutics, Inc. or its management. Marker Therapeutics, Inc. does not by its reference below imply its endorsement of or concurrence with such information, conclusions or recommendations. Furthermore, Marker Therapeutics, Inc. may not and is not obligated to update publicly any such coverage information as changes may occur in the future.

Christopher Marai, Ph.D
Nomura | Instinet

Edward Tenthoff
Piper Jaffray

Matthew Biegler
Oppenheimer & Co Inc.

Yun Zhong, Ph.D
Janney Montgomery Scott

Tony Butler, Ph.D
Roth Capital Partners

Steve Brozak, DMH
WBB Securities LLC